# | PDB (Resolution Å) |
Site # | Ligand | EC number | GO terms | UniProt | PubMed | Binding affinity |
---|---|---|---|---|---|---|---|---|
1 | 4ev5:A (2.25) | BS01 | CU | 1.4.3.21 | GO:0005507 ... | P12807 | N/A | |
2 | 4ev5:A (2.25) | BS02 | ABN | 1.4.3.21 | GO:0005507 ... | P12807 | N/A | |
3 | 4ev5:B (2.25) | BS01 | CU | 1.4.3.21 | GO:0005507 ... | P12807 | N/A | |
4 | 4ev5:B (2.25) | BS02 | ABN | 1.4.3.21 | GO:0005507 ... | P12807 | N/A | |
5 | 4ev5:C (2.25) | BS01 | CU | 1.4.3.21 | GO:0005507 ... | P12807 | N/A | |
6 | 4ev5:C (2.25) | BS02 | ABN | 1.4.3.21 | GO:0005507 ... | P12807 | N/A | |
7 | 4ev5:D (2.25) | BS01 | CU | 1.4.3.21 | GO:0005507 ... | P12807 | N/A | |
8 | 4ev5:D (2.25) | BS02 | ABN | 1.4.3.21 | GO:0005507 ... | P12807 | N/A | |
9 | 4ev5:E (2.25) | BS01 | CU | 1.4.3.21 | GO:0005507 ... | P12807 | N/A | |
10 | 4ev5:E (2.25) | BS02 | ABN | 1.4.3.21 | GO:0005507 ... | P12807 | N/A | |
11 | 4ev5:F (2.25) | BS01 | CU | 1.4.3.21 | GO:0005507 ... | P12807 | N/A | |
12 | 4ev5:F (2.25) | BS02 | ABN | 1.4.3.21 | GO:0005507 ... | P12807 | N/A |